Skip to main content
63°
Cloudy
Site search
Search
Menu
Search
Subscribe
Open user controls
Log In Using Your Account
Log In
Don't have an account?
Sign Up Today
My Account
Dashboard
Profile
Saved items
Logout
Home
News
Local News
State News
Sports
Local Sports
Pro Sports
Lifestyle
Local Entertainment
Multimedia
Community Choice
Features
Special Sections
Local Events
Weather
Classifieds
Place Ad
Legal Notices
Place Call Legal
Search Call Legals
Place Times Legal
Search Times Legals
Public Notices
Obituaries
E-Edition
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries
Anika Therapeutics Inc. - Common Stock
(NQ:
ANIK
)
8.235
-0.025 (-0.30%)
Streaming Delayed Price
Updated: 11:37 AM EDT, Aug 1, 2025
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Anika Therapeutics Inc. - Common Stock
< Previous
1
2
3
4
Next >
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Anika Therapeutics, Inc. - ANIK
Today 10:00 EDT
From
Pomerantz LLP
Via
GlobeNewswire
Anika (ANIK) Q2 Revenue Beats by 4%
July 31, 2025
Via
The Motley Fool
Topics
Economy
12 Health Care Stocks Moving In Wednesday's Intraday Session
July 30, 2025
Via
Benzinga
ANIKA THERAPEUTICS INC (NASDAQ:ANIK) Reports Mixed Q2 2025 Results with Revenue Beat but EPS Miss, Shares Drop 9% in Pre-Market
July 30, 2025
Anika Therapeutics reported mixed Q2 2025 results, with revenue beating estimates but EPS missing. Shares fell 9% amid Hyalofast trial concerns despite strong regenerative solutions growth.
Via
Chartmill
Earnings Scheduled For July 30, 2025
July 30, 2025
Via
Benzinga
What's Next: Anika Therapeutics's Earnings Preview
October 30, 2024
Via
Benzinga
Anika Reports Topline Results from U.S. Pivotal FastTRACK Phase III Study for Hyalofast® Cartilage Repair Scaffold and Provides Program Update
July 30, 2025
From
Anika Therapeutics Inc.
Via
GlobeNewswire
Anika to Issue Second Quarter 2025 Financial Results on Wednesday, July 30, 2025
July 16, 2025
From
Anika Therapeutics Inc.
Via
GlobeNewswire
Anika Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
July 03, 2025
From
Anika Therapeutics Inc.
Via
GlobeNewswire
Anika Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
June 05, 2025
From
Anika Therapeutics Inc.
Via
GlobeNewswire
Anika Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
May 12, 2025
From
Anika Therapeutics Inc.
Via
GlobeNewswire
Earnings Scheduled For May 9, 2025
May 09, 2025
Via
Benzinga
A Glimpse of Anika Therapeutics's Earnings Potential
May 08, 2025
Via
Benzinga
Anika to Participate in the Sidoti Virtual Investor Conference
May 07, 2025
From
Anika Therapeutics Inc.
Via
GlobeNewswire
Anika to Issue First Quarter 2025 Financial Results on Friday, May 9, 2025
April 25, 2025
From
Anika Therapeutics Inc.
Via
GlobeNewswire
Anika Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
April 07, 2025
From
Anika Therapeutics Inc.
Via
GlobeNewswire
Microsoft To Rally More Than 17%? Here Are 10 Top Analyst Forecasts For Thursday
March 13, 2025
Via
Benzinga
US Stocks Likely To Open Lower After A Brief Respite: 'Add Exposure To Equities' Amid Pullback, Says Expert
March 13, 2025
U.S. stock futures fell again on Thursday after a brief respite on Wednesday, following a softer-than-expected inflation print.
Via
Benzinga
Topics
Economy
Why Intel Shares Are Trading Higher By Over 10%; Here Are 20 Stocks Moving Premarket
March 13, 2025
Via
Benzinga
Anika Completes Divestiture of Parcus Medical
March 07, 2025
Execution of Previously Announced Plan Sharpens Focus on Hyaluronic Acid-Driven OA Pain Management and High Growth Regenerative Solutions Portfolio
From
Anika Therapeutics Inc.
Via
GlobeNewswire
Earnings Scheduled For March 12, 2025
March 12, 2025
Via
Benzinga
Anika to Issue Fourth Quarter and Year-End 2024 Financial Results on Wednesday, March 12, 2025
February 26, 2025
From
Anika Therapeutics Inc.
Via
GlobeNewswire
Anika To Present at the Canaccord Genuity 2025 Musculoskeletal Conference
February 25, 2025
From
Anika Therapeutics Inc.
Via
GlobeNewswire
Anika To Participate in 43rd Annual J.P. Morgan Healthcare Conference
December 23, 2024
From
Anika Therapeutics Inc.
Via
GlobeNewswire
Anika To Participate in December 2024 Investor Conferences
November 22, 2024
From
Anika Therapeutics Inc.
Via
GlobeNewswire
12 Health Care Stocks Moving In Thursday's Intraday Session
October 31, 2024
Via
Benzinga
Anika Announces Strategic Update of Business with Sale of Arthrosurface and Plan to Divest Parcus Medical
October 31, 2024
Company to Focus on Profitable Hyaluronic Acid-Driven OA Pain Management and High Growth Regenerative Solutions Portfolio, Streamline Operations and Enhance Growth Profile
From
Anika Therapeutics Inc.
Via
GlobeNewswire
Anika Announces Third Quarter 2024 Results Conference Call Date
October 17, 2024
From
Anika Therapeutics Inc.
Via
GlobeNewswire
Anika Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
October 04, 2024
From
Anika Therapeutics Inc.
Via
GlobeNewswire
Anika Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
September 09, 2024
From
Anika Therapeutics Inc.
Via
GlobeNewswire
< Previous
1
2
3
4
Next >
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms Of Service
.
